financetom
Business
financetom
/
Business
/
SiriusPoint to Sell 49% Stake in Arcadian Risk to Lee Equity for $139 Million
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
SiriusPoint to Sell 49% Stake in Arcadian Risk to Lee Equity for $139 Million
Oct 6, 2025 4:00 AM

06:32 AM EDT, 10/06/2025 (MT Newswires) -- SiriusPoint ( SPNT ) said Monday it will sell its 49% stake in Arcadian Risk Capital to Lee Equity Partners for $139 million, including a pre-close dividend.

The company said it has also renewed and extended its capacity partnership with Arcadian through 2031.

The deal is expected to close by Q1 2026, and SiriusPoint ( SPNT ) expects to record an additional pre-tax gain of $25 million to $30 million, on top of a $96 million gain reported in Q2 2024, it added.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Executives from Mercuria, Rolex other Swiss firms meet Trump
Executives from Mercuria, Rolex other Swiss firms meet Trump
Nov 5, 2025
WASHINGTON, Nov 5 (Reuters) - Executives of MSC, Rolex, Partners Group, Mercuria, Richemont and MKS took part in a meeting of Swiss business leaders with U.S. President Donald Trump in the Oval Office on Tuesday, according to a statement seen by Reuters. Switzerland is facing 39% U.S. tariffs on imports of its goods and both its government and private sector...
US Physical Therapy Q3 revenue up nearly 18% on new clinic additions
US Physical Therapy Q3 revenue up nearly 18% on new clinic additions
Nov 5, 2025
Overview * US Physical Therapy ( USPH ) Q3 revenue grows 17.8% but misses analyst expectations * Adjusted EPS for Q3 misses consensus at $0.66 * Company added 18 clinics in Q3, contributing to revenue growth Outlook * Company reaffirms full-year 2025 Adjusted EBITDA guidance of $93.0 mln to $97.0 mln * Company expects 2026 growth from key initiatives and...
RCM Technologies beats Q3 revenue estimates
RCM Technologies beats Q3 revenue estimates
Nov 5, 2025
Overview * RCM Technologies Q3 revenue grows 16.4% yr/yr, beating analyst expectations * Company reports GAAP net income of $2.3 mln, down from $2.7 mln last year * Company expects record gross profit and adjusted EBITDA in fiscal Q4 2025 Outlook * RCM Technologies expects record gross profit and adjusted EBITDA in Q4 fiscal 2025 Result Drivers * ENGINEERING BACKLOG...
Immuno-oncology firm Genelux's Q3 net loss beats expectations
Immuno-oncology firm Genelux's Q3 net loss beats expectations
Nov 5, 2025
Overview * Genelux ( GNLX ) Q3 net loss of $7.95 mln beats analyst expectations * Company has $21 mln in cash and investments, funding operations into Q3 2026 Outlook * Company expects cash resources to support operations into Q3 2026 Result Drivers * R&D EXPENSES - Increase in R&D expenses driven by stock compensation and clinical trial costs for...
Copyright 2023-2026 - www.financetom.com All Rights Reserved